Molecular Detection of Class-D OXA Carbapenemase Genes in Biofilm and Non-Biofilm Forming Clinical Isolates of Acinetobacter baumannii

Jundishapur Journal of Microbiology
Omid AziziFereshteh Shahcheraghi

Abstract

Emergence and spread of carbapenemase (bla OXA) genes in multidrug resistant Acinetobacter baumannii (MDR-AB) forming biofilm complicated treatment of the patients infected with this microorganism particularly in intensive care units (ICUs). The current study aimed to determine the prevalence of molecular class-D OXA carbapenemase in biofilm and non-biofilm forming strains of MDR-AB. A total of 65 strains of MDR-AB were isolated from the patients hospitalized in the ICU of two hospitals in Kerman, Iran. The isolates were identified by conventional microbiological tests as well as API 20NE assay. Antibiotic susceptibility was carried out by disk diffusion method; minimum inhibitory concentration (MIC) of carbapenems was measured by E-test. The presence of bla OXA genes among the isolates were studied by duplex-polymerase chain reaction and application of appropriate primers. Biofilm formation was detected by microtiter plate method. The isolates were highly resistant to ciprofloxacin, levofloxacin, piperacillin, nalidixic acid and third generation cephalosporins such as tigecycline (7%; n = 5) and colistin (13%; n = 8). Among the isolates, 77% (n = 50) exhibited high MIC (265μg/mL) for imipenem. Both the bla OXA-51 and bla OXA-2...Continue Reading

References

Sep 1, 1987·Annales De L'Institut Pasteur. Microbiology·P J Bouvet, P A Grimont
Nov 26, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J M Cisneros, J Rodríguez-Baño
Jul 5, 2003·Journal of Clinical Microbiology·Libera M Dalla-CostaNeil Woodford
Jun 30, 2005·Current Opinion in Infectious Diseases·Shiri Navon-VeneziaYehuda Carmeli
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Dec 8, 2005·The Journal of Antimicrobial Chemotherapy·Susan Brown, Sebastian Amyes
Mar 28, 2006·International Journal of Antimicrobial Agents·Neil WoodfordDavid M Livermore
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Poirel, P Nordmann
Aug 19, 2006·The Journal of Antimicrobial Chemotherapy·T W BooB Crowley
Aug 19, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Srdjan StepanovićFilip Ruzicka
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Jun 24, 2008·International Journal of Antimicrobial Agents·Helen GiamarellouKyriaki Kanellakopoulou
Oct 15, 2011·International Journal of Antimicrobial Agents·Han-Yueh KuoMing-Li Liou
Feb 23, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Nasrollah SohrabiNazli Saeedi
Nov 19, 2013·Mikrobiyoloji bülteni·Ihsan Hakkı CiftciAhmet Ayyildiz

❮ Previous
Next ❯

Citations

Sep 10, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Farzan ModarresiShahla Mansouri
Jun 16, 2016·Jundishapur Journal of Microbiology·Joanna Kwiecinska-PirogEugenia Gospodarek-Komkowska

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
Giovanni BuccolieroSalvatore Pisconti
Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive
R RicciardiG Danzi
© 2021 Meta ULC. All rights reserved